Concepedia

Melissa Holtz

MH

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

2002

Affiliations

City Of Hope National Medical Center(Current)

City of Hope

Melissa Holtz is an author at City Of Hope National Medical Center specializing in chronic myeloid leukemia therapy, cell biology, and hematologic malignancy therapy.

Publications per year

2002–2008

8

Publications

8

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

Ravi Bhatia, Melissa Holtz, Ning Niu et al. · Blood · 2003 · 541 citations · Full text

, , +15

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

Melissa Holtz, Marilyn L. Slovak, Feiyu Zhang et al. · Blood · 2002 · 250 citations · Full text

, , +7

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells

Su Chu, Melissa Holtz, Mamta Gupta et al. · Blood · 2003 · 162 citations · Full text

, , +11

Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli

Melissa Holtz, Stephen J. Forman, Ravi Bhatia · Leukemia · 2005 · 138 citations

, , +15

Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors

Helmut König, Melissa Holtz, Hardik Modi et al. · Leukemia · 2008 · 108 citations

, , +12

1–5 of 8